Log 10 vs Log 7 - the 1,000x Difference That Matters in a Hospital

When evaluating point-of-use water filters for a healthcare facility, two numbers appear more often than any others: the pore size in microns and the log reduction value. Both describe how thoroughly a filter removes bacteria from water. Both are independently certified under recognized US and international standards. And both differ significantly between filters that carry the same general description, "anti-Legionella", but perform quite differently in practice.

Understanding what these numbers actually mean, how they are measured, and why the differences matter in a clinical setting is not a technical exercise. It is the difference between a documented intervention and a documented gap.

What Log Reduction Means

Log reduction is a way of expressing bacterial removal as a power of ten. A filter certified to Log 7 removes 99.99999 percent of bacteria per liter of water treated. A filter certified to Log 10 removes 99.99999999 percent.

Those percentages look similar. The underlying math is not.

Log reduction	Percentage removed	Bacteria remaining (per 1,000,000 present)
Log 6	99.9999%	1
Log 7	99.99999%	0.1
Log 10	99.99999999%	0.0001

A three-log gap -from Log 7 to Log 10 -means 1,000 times more bacteria eliminated per liter of water processed. If water entering a filter contains one million bacterial cells, a Log 7 filter passes approximately 0.1 cells per liter. A Log 10 filter passes approximately 0.0001. In practical terms, the higher the log value, the closer the filter gets to zero detectable organisms in the treated water.

This is the standard against which independent laboratories test and certify water filters. In the United States, the primary certification standard for anti-Legionella point-of-use filters is ASTM F838-20, which tests the filter's ability to reduce Legionella pneumophila to a specific log value. Testing is conducted by accredited third-party laboratories, primarily IAPMO, an ANSI-accredited body, rather than by the manufacturer.

When evaluating any filter's log reduction claim, the first question is always: certified by whom? A manufacturer's self-reported log reduction and a third-party certified log reduction are not equivalent statements.

What Pore Size Means? and Why 0.08 µm Differs from 0.2 µm

Point-of-use filters work by physical separation: water is pushed through a membrane, and anything larger than the pore cannot pass through. The pore size determines what the membrane can and cannot stop.

Legionella pneumophila cells range from approximately 0.3 to 0.9 micrometers in diameter. Nontuberculous Mycobacteria (NTM) range from 0.2 to 5 µm. Pseudomonas aeruginosa is typically 0.5 to 0.7 µm. E. coli is 1 to 2 µm.

A 0.2 µm membrane will stop Legionella pneumophila in its typical size range  and this is the specification that most point-of-use filters on the market carry. However, Legionella in the smallest part of its size range, and certain NTM strains, approach the 0.2 µm threshold. A filter rated nominally, rather than absolutely, at 0.2 µm does not guarantee that all particles above that threshold are retained.

A 0.08 µm membrane operates in the ultrafiltration range, a full category finer than microfiltration. At 0.08 µm, the pore is physically smaller than the smallest relevant Legionella cell. The barrier is not probabilistic; it is categorical. This is the design rationale behind choosing 0.08 µm as a membrane specification for clinical environments: not a margin improvement, but a mechanism change.

Why This Gap Matters Specifically in High-Risk Clinical Settings

In most healthy adults, the immune system can clear low levels of waterborne bacteria before they cause illness. The regulatory thresholds in typical water management programs, temperature targets, disinfectant concentrations, colony-forming unit limits - are calibrated with this baseline resilience in mind.

In an oncology unit, a bone marrow transplant ward, an ICU, or a neonatal unit, that baseline does not apply. Patients receiving immunosuppressive chemotherapy, patients whose immune systems have been ablated ahead of transplant, premature neonates, and critically ill ventilated patients have no meaningful defense against waterborne pathogens. For these populations, the gap between Log 7 and Log 10 is not academic.

Transplant and oncology units often require point-of-use filtration on all patient water sources precisely because even low-level Legionella or NTM exposure can cause life-threatening infections in immunocompromised patients. The question of filter specification in these environments is a clinical risk question, not just a procurement one.

It is also an inspection question. When a CMS surveyor or Joint Commission inspector reviews water management documentation for a hematology unit, they will want to see not just that POU filters are installed, but what those filters are certified to achieve. A filter certified to Log 7 by an accredited third-party laboratory is a documented intervention. A filter with a higher certified performance provides a wider documented safety margin and that difference matters when an inspection follows an adverse event.

The Certification Questions to Ask About Any Filter

When reviewing a point-of-use filter for procurement, these are the questions that determine whether the specification is adequate for a high-risk clinical environment:

• What log reduction is it certified to? Log 6, 7, and 10 all appear on the market. The certified value, not the claimed value, is what matters.

• Certified by whom? IAPMO (ANSI-accredited), NSF International, or an equivalent accredited third-party laboratory is the standard. Self-certification by the manufacturer is not equivalent.

• Under which standard? ASTM F838-20 is the US standard for bacterial retention. NSF P376 covers bacteria and fungi reduction. ASSE LEC 2011-2022 is the US water engineering standard for bacteria reduction at point of use.

• What is the pore size, and is it absolute-rated? A nominal pore size and an absolute pore size are different specifications. An absolute-rated 0.08 µm membrane makes a stronger and more verifiable construction claim.

• What is the certified filter life? A filter certified for 150 days has been tested at that duration. Shorter-life filters require more frequent replacement cycles, with all the associated installation risk and program administration burden.

The Broader Principle

Log reduction and pore size are the two numbers that define what a point-of-use filter actually does. Everything else, housing material, flow rate, installation mechanism, price - is secondary to those two specifications when the filter is being used as a patient safety intervention in a high-risk clinical environment.

The market for anti-Legionella POU filters has grown significantly as regulatory requirements have tightened. That growth has brought a wide range of products to market under the same general label. Not all of them carry the same certified performance. Reading the certification documentation carefully and understanding what log reduction and pore size specifications mean for the specific patient population a facility serves, is the starting point for any procurement decision that genuinely reduces risk rather than simply demonstrating that a filter is present.

Questions about POU filter certification and specification for your facility?    Contact the MWT team.